This new paper dedicated to hiPSC expansion with the C-Stem™ technology platform shows that:
- hiPSCs seeded in C-Stem™-generated capsules self-organize into in vivo-like 3D lumenized colonies (morphologically reminiscent of epiblasts).
- Unprecedented >275-fold amplification of hiPSCs within 6.5 days in 10L bioreactors, with high reproducibility and maintenance of cell quality
- C-Stem™ maintains the pluripotency and genomic integrity of hiPSCs throughout exponential expansion.
Overall, this publication opens new perspectives for the mass production of high-quality hiPSC-derived cell therapy products.
We asked our co-founder and Chief Scientific Officer, Maxime Feyeux, to answer a series of frequently asked questions: